XT
CLGN icon

XTX Topco’s CollPlant Biotechnologies CLGN Stock Holding History

XTX Topco’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.56K Sell
1,308
-172
-12% -$663 ﹤0.01% 4074
2026
Q1 		$7.92K Buy
1,480
+42
+3% +$424 ﹤0.01% 3724
2025
Q4 		$20.3K Buy
+1,438
New +$29.4K ﹤0.01% 3058

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's CLGN Position: Q2 2026 in Review

XTX Topco reduced its CollPlant Biotechnologies (CLGN) stake by 12% in Q2 2026, selling an estimated $663 and leaving 1,308 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

XTX Topco first reported a position in CLGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.3K in Q4 2025. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • XTX Topco held 1,308 shares of CollPlant Biotechnologies worth $4.56K as of Q2 2026.
  • XTX Topco sold 172 CollPlant Biotechnologies shares in Q2 2026, an estimated $663.
  • CollPlant Biotechnologies made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4074 holding.
  • XTX Topco first reported a position in CollPlant Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • XTX Topco's CollPlant Biotechnologies position peaked at $20.3K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.